Cargando…
Efficacy and safety of rectal nonsteroidal anti-inflammatory drugs for prophylaxis against post-ERCP pancreatitis: a systematic review and meta-analysis
Rectal nonsteroidal anti-inflammatory drugs (NSAIDs) are not commonly used clinically for preventing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. To evaluate the efficacy and safety of NSAIDs for post-ERCP prophylaxis, we systematically reviewed sixteen randomized control...
Autores principales: | Hou, Yi-Chao, Hu, Qiang, Huang, Jiao, Fang, Jing-Yuan, Xiong, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404221/ https://www.ncbi.nlm.nih.gov/pubmed/28440297 http://dx.doi.org/10.1038/srep46650 |
Ejemplares similares
-
Rectal nonsteroidal anti-inflammatory drugs, glyceryl trinitrate, or combinations for prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: A network meta-analysis
por: Shi, Qing-Qing, et al.
Publicado: (2022) -
Risk Factors for Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis and the Effect of Octreotide Combined with Nonsteroidal Anti-Inflammatory Drugs on Preventing Its Occurrence
por: Wang, Jin, et al.
Publicado: (2018) -
Post-ERCP Pancreatitis: Risk factors and role of NSAIDs in primary prophylaxis
por: Nawaz, Muhammad Haseeb, et al.
Publicado: (2020) -
Underutilization of prophylactic rectal indomethacin and pancreatic duct stent for prevention of post-ERCP Pancreatitis
por: Issak, Abdulfatah, et al.
Publicado: (2021) -
Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials
por: Zheng, Minghua, et al.
Publicado: (2007)